{"brief_title": "RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease", "brief_summary": "The objective of the study is to determine the safety and tolerability of RG2133 in patients with Mitochondrial Disease.", "condition": "Mitochondrial Diseases", "intervention_type": "Drug", "intervention_name": "RG2133 (2',3',5'-tri-O-acetyluridine)", "criteria": "Mitochondrial Disease", "gender": "All", "minimum_age": "3 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00060515.xml"}